75Y-11710-69582
3 vaccinations
3 coded responses
17 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 875 / NM
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-25
- 2020-12-30
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-03-17
- 2021-06-16
- 2021-07-14
-
2021-10-13
Dose 3 — Pfizer-BioNTech
-
2021-11-14
Survey response — day 28, dose 3MedDRA: Dyspnoea, Palpitations, Vertigo — Feeling: FairFree text: Shortness of breath heart palpitations vertigoMedDRA releases: 2024-11 · check-in free text available
- 2021-11-17
- 2021-11-24
-
2022-01-12
Survey response — 3 months, dose 3MedDRA: Supraventricular extrasystoles — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Premature atrial contractions.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-04-15
Survey response — 6 months, dose 3MedDRA: Palpitations — Feeling: GoodFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
- 2022-04-29
- 2022-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-10-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-12 | Unsuccessful |
Free text
Release 10 — day 28, dose 3
Symptoms: Shortness of breath heart palpitations vertigo
Release 10 — 3 months, dose 3
Symptoms: Premature atrial contractions.
Release 11 — 6 months, dose 3
Symptoms: Heart palpitations
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Supraventricular extrasystoles | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release